NC
TMCI icon

nVerses Capital’s Treace Medical Concepts TMCI Stock Holding History

nVerses Capital’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.6K Buy
+10,696
New +$29.4K 0.07% 278

Other funds holding TMCI

LS
LCW Services Virginia Beach, Virginia $230M AUM
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return
TFA
TrustWell Financial Advisors Jacksonville, Florida $118M AUM
TCOT
Trust Company of Toledo Holland, Ohio $1.2B AUM 33.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

nVerses Capital's TMCI Position: Q2 2026 in Review

nVerses Capital opened a new position in Treace Medical Concepts (TMCI) in Q2 2026: 10,696 shares worth $42.6K. The stake represents 0.07% of the portfolio and ranks #278 among its holdings.

23 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • nVerses Capital held 10,696 shares of Treace Medical Concepts worth $42.6K as of Q2 2026.
  • Treace Medical Concepts was a new nVerses Capital position in Q2 2026.
  • Treace Medical Concepts made up 0.07% of nVerses Capital's portfolio in Q2 2026, its #278 holding.
  • 23 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.